KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Retained Earnings (2018 - 2025)

Historic Retained Earnings for Vir Biotechnology (VIR) over the last 8 years, with Q3 2025 value amounting to -$1.2 billion.

  • Vir Biotechnology's Retained Earnings fell 7626.02% to -$1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.2 billion, marking a year-over-year decrease of 7626.02%. This contributed to the annual value of -$759.8 million for FY2024, which is 21947.32% down from last year.
  • According to the latest figures from Q3 2025, Vir Biotechnology's Retained Earnings is -$1.2 billion, which was down 7626.02% from -$991.7 million recorded in Q2 2025.
  • Over the past 5 years, Vir Biotechnology's Retained Earnings peaked at $774.3 million during Q2 2021, and registered a low of -$1.2 billion during Q3 2025.
  • Moreover, its 5-year median value for Retained Earnings was -$237.8 million (2023), whereas its average is -$241.8 million.
  • As far as peak fluctuations go, Vir Biotechnology's Retained Earnings skyrocketed by 37217.68% in 2022, and later plummeted by 116221.55% in 2024.
  • Vir Biotechnology's Retained Earnings (Quarter) stood at -$138.6 million in 2021, then skyrocketed by 372.18% to $377.2 million in 2022, then plummeted by 163.04% to -$237.8 million in 2023, then crashed by 219.47% to -$759.8 million in 2024, then crashed by 52.0% to -$1.2 billion in 2025.
  • Its Retained Earnings was -$1.2 billion in Q3 2025, compared to -$991.7 million in Q2 2025 and -$880.7 million in Q1 2025.